Tyler Jacks | |
|---|---|
| Alma mater | Harvard University University of California, San Francisco |
| Scientific career | |
| Fields | Cancer Research |
| Institutions | David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology |
| Academic advisors | Robert Weinberg |
Tyler Jacks is a David H. Koch Professor of Biology at the Massachusetts Institute of Technology (MIT), a long-time HHMI investigator, and Founding Director of the David H. Koch Institute for Integrative Cancer Research, which brings together biologists and engineers to improve detection, diagnosis, and treatment of cancer.[1] Dr. Jacks is a member of the board of directors of Thermo Fisher Scientific and Amgen, two of the major biotechnology corporations in the world.[2][3] He is the President of Break Through Cancer and a member of the Board of Overseers, the larger of two governing boards of Harvard University.[4]